Symptomatic Necrosis With Antibody-Drug Conjugates and Concurrent Stereotactic Radiotherapy for Brain Metastases

Authors: Emily S. Lebow, Luke Pike, Andrew D. Seidman, Nelson S. Moss, Kathryn Beal, Yao Yu - JAMA Oncology 2023 cited by 63

This cohort study investigates whether brain metastases that manifest after stereotactic radiotherapy with concurrent antibody-drug conjugates are associated with an increased risk of symptomatic radiation necrosis.